Prasol Chemicals Q2 Net Profit Jumps to Rs 379 Million

CHEMICALS
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Prasol Chemicals Q2 Net Profit Jumps to Rs 379 Million

Prasol Chemicals reported a significant financial performance for the quarter ended September 30, 2026, with revenue rising to Rs 4,125.66 million and net profit reaching Rs 379.75 million. The company also detailed the successful completion of its Rs 5,000 million IPO, which listed on exchanges this September. Investors should watch if this strong growth trajectory sustains in the coming quarters.

Prasol Chemicals Q2 Net Profit Soars to Rs 379 Million

Revenue grew to Rs 4,125.66 million for the quarter, while half-year net profit jumped to Rs 989.98 million.

Reader Takeaway: Revenue growth remains strong, though investors must track how the company maintains margins in the competitive specialty chemicals sector.

What just happened

Prasol Chemicals has released its financial results for the quarter and half-year ended September 30, 2026. The company reported a significant increase in both top-line revenue and bottom-line profitability. Quarterly revenue touched Rs 4,125.66 million compared to Rs 2,976.50 million in the same quarter last year. Net profit after tax for the half-year stood at Rs 989.98 million, up from Rs 414.50 million during the same period in 2025.

Why this matters

The results highlight operational efficiency in the specialty chemicals segment. The jump in earnings per share (EPS) to Rs 6.52 for the quarter reflects strong fundamental performance post-expansion. The company also successfully concluded its Rs 5,000 million IPO, listing on the NSE and BSE on September 16, 2026. This move provided necessary capital, with Rs 800 million raised through a fresh issue to bolster business operations.

The backstory

The IPO consisted of 7,396,437 equity shares issued at Rs 676 per share. The issue included an offer for sale by existing shareholders totaling Rs 4,200 million. IPO-related expenses of Rs 29.27 million were adjusted against the Securities Premium Account.

Governance and Operations

Statutory auditors have provided an unmodified limited review report, signaling no major accounting concerns. The company operates exclusively in the specialty chemicals business, simplifying its financial reporting structure.

What to track next

Investors should monitor whether the company can maintain these growth levels in subsequent quarters and how effectively it deploys the fresh capital raised from the IPO to scale its specialty chemical production.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.